Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 38.61%-84.48M | 96.79%326.01M | 37.05%215.31M | 154.14%107.13M | 42.65%141.19M | -3.81%-137.62M | 147.14%165.66M | -34.13%157.1M | -45.14%42.15M | 205.48%98.97M |
Net income from continuing operations | -36.91%8.92M | 63.75%236.94M | 0.34%81.5M | 136.17%69.38M | 105.50%71.93M | 1,658.54%14.14M | -25.63%144.69M | 31.06%81.22M | -34.02%29.38M | -47.55%35M |
Operating gains losses | -756.42%-3.73M | -160.01%-7.27M | -187.13%-2.03M | -485.11%-4.01M | -145.49%-796K | 86.18%-436K | -113.87%-2.8M | 70.29%-707K | -56.75%-685K | 3,877.27%1.75M |
Depreciation and amortization | 25.53%63.4M | 9.41%221.6M | 27.58%65.18M | 9.60%56.07M | -1.87%49.85M | 2.05%50.51M | 14.16%202.54M | -0.88%51.09M | 13.34%51.16M | 15.19%50.79M |
Deferred tax | -130.23%-9.18M | -207.72%-30.54M | -257.91%-16.62M | -547.74%-6.53M | 68.80%-3.41M | 63.70%-3.99M | 61.83%-9.92M | 207.38%10.52M | 129.13%1.46M | -68,118.75%-10.92M |
Other non cash items | -98.88%1.48M | 214.28%86.1M | 164.74%74.66M | -164.17%-20.33M | -261.17%-100.02M | 345.14%131.79M | -122.62%-75.34M | -189.61%-115.31M | 165.25%31.68M | -52.36%62.06M |
Change In working capital | 54.80%-152.01M | -88.12%-226.86M | -110.40%-12.47M | 107.50%5.73M | 356.67%116.19M | -182.83%-336.31M | 81.56%-120.59M | 16,815.51%119.93M | -309.55%-76.35M | 78.77%-45.27M |
-Change in receivables | 552.32%30.27M | -3.06%-209.95M | 35.10%-45.72M | 8.63%-69.94M | -266.81%-98.93M | 115.60%4.64M | 56.57%-203.73M | -33.16%-70.45M | 2.14%-76.55M | 83.75%-26.97M |
-Change in payables and accrued expense | 17.69%-38.39M | 229.12%79.23M | 174.36%41.1M | 727.42%41.03M | 1,748.08%43.74M | -1,599.26%-46.64M | -256.66%-61.36M | -215.99%-55.28M | -863.01%-6.54M | 86.18%-2.65M |
-Change in other current liabilities | 105.82%8.58M | -166.53%-96.14M | -146.73%-56.3M | 81.91%-3.93M | 363.37%111.47M | -267.39%-147.38M | 204.23%144.49M | 267.01%120.47M | -131.35%-21.7M | 52.24%-42.32M |
-Change in other working capital | -3.77%-152.48M | ---- | ---- | 35.61%38.57M | 124.58%59.91M | 18.51%-146.93M | ---- | ---- | -36.22%28.44M | -55.93%26.68M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 38.61%-84.48M | 96.79%326.01M | 37.05%215.31M | 154.14%107.13M | 42.65%141.19M | -3.81%-137.62M | 147.14%165.66M | -34.13%157.1M | -45.14%42.15M | 205.48%98.97M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 80.29%-9.83M | -484.48%-783.1M | -21.71%-68.75M | -4,908.90%-497.03M | -160.06%-167.46M | -1,470.64%-49.85M | 84.65%-133.98M | 87.97%-56.49M | 93.63%-9.92M | 80.53%-64.39M |
Net PPE purchase and sale | 13.15%-14.65M | 23.00%-65.09M | 18.82%-19.57M | 16.49%-16.16M | -842.68%-233.4M | 70.34%-16.87M | 63.05%-84.52M | 87.10%-24.11M | -5.21%-19.35M | -82.31%-24.76M |
Net business purchase and sale | -2,359.69%-11.17M | -728.82%-537.73M | -1,722.91%-65.32M | -28,368.25%-454.64M | 70.23%-17.77M | ---454K | 93.56%-64.88M | 99.13%-3.58M | 99.25%-1.6M | 81.81%-59.7M |
Net other investing changes | 149.18%16M | -1,269.28%-180.29M | -544.63%-180.45M | -177.41%-10.56M | 317.22%83.71M | -160.56%-32.53M | -95.75%15.42M | -145.01%-27.99M | -82.10%13.64M | -74.74%20.06M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 80.29%-9.83M | -484.48%-783.1M | -21.71%-68.75M | -4,908.90%-497.03M | -160.06%-167.46M | -1,470.64%-49.85M | 84.65%-133.98M | 87.97%-56.49M | 93.63%-9.92M | 80.53%-64.39M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -32.14%119.38M | 5,893.13%452.21M | -53.81%-183.73M | 929.27%396.14M | 3,016.49%63.89M | 11.79%175.91M | -101.27%-7.81M | -156.91%-119.45M | -144.32%-47.77M | -99.19%2.05M |
Net issuance payments of debt | 235.08%141.91M | 140.72%221.57M | -68.20%-198.11M | 4,348.78%418.21M | 125.47%106.53M | -160.93%-105.05M | -90.09%92.05M | -146.37%-117.78M | -107.15%-9.84M | -86.33%47.25M |
Net common stock issuance | --0 | --286.92M | --0 | --0 | --0 | --286.92M | --0 | --0 | --0 | --0 |
Cash dividends paid | -6.45%-7.59M | -8.56%-14.67M | --0 | -6.57%-7.54M | --0 | -10.75%-7.13M | -3.18%-13.52M | --0 | -9.01%-7.08M | --0 |
Proceeds from stock option exercised by employees | -91.87%1.15M | 7.21%45.09M | -13.07%16.57M | 49.73%11.13M | --3.27M | -9.26%14.13M | 150.66%42.06M | 331.60%19.06M | 570.76%7.43M | --0 |
Net other financing activities | -24.13%-16.09M | 32.47%-86.7M | 89.48%-2.18M | 32.99%-25.65M | -1.57%-45.91M | 46.42%-12.96M | 16.67%-128.39M | -125.75%-20.72M | -56.41%-38.28M | -17.11%-45.2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -32.14%119.38M | 5,893.13%452.21M | -53.81%-183.73M | 929.27%396.14M | 3,016.49%63.89M | 11.79%175.91M | -101.27%-7.81M | -156.91%-119.45M | -144.32%-47.77M | -99.19%2.05M |
Net cash flow | ||||||||||
Beginning cash position | -0.50%217.98M | 10.06%219.08M | 2.79%245.26M | -6.56%240.69M | -7.72%205.46M | 10.06%219.08M | -53.20%199.04M | 10.75%238.59M | 24.76%257.58M | -16.17%222.65M |
Current changes in cash | 316.96%25.08M | -120.45%-4.88M | -97.34%-37.17M | 140.13%6.24M | 2.69%37.61M | -153.46%-11.56M | 112.38%23.87M | 10.40%-18.84M | -153.70%-15.54M | 181.44%36.63M |
Effect of exchange rate changes | 12.82%-1.8M | 198.65%3.79M | 1,557.44%9.9M | 51.76%-1.66M | -40.02%-2.39M | -203.47%-2.06M | 88.48%-3.84M | -114.68%-679K | 82.72%-3.45M | 87.97%-1.7M |
End cash Position | 17.43%241.26M | -0.50%217.98M | -0.50%217.98M | 2.79%245.26M | -6.56%240.69M | -7.72%205.46M | 10.06%219.08M | 10.06%219.08M | 10.75%238.59M | 24.76%257.58M |
Free cash flow | 35.83%-99.13M | 221.58%260.92M | 47.18%195.73M | 298.92%90.97M | -224.25%-92.21M | 18.45%-154.49M | 150.18%81.14M | 157.81%132.99M | -60.98%22.8M | 294.38%74.21M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |